SM4 The New SMC Ultra-Orphan Pathway: HTA Best Practice for Very Rare Diseases?
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.1213
https://www.valueinhealthjournal.com/article/S1098-3015(21)01430-3/fulltext
Title :
SM4 The New SMC Ultra-Orphan Pathway: HTA Best Practice for Very Rare Diseases?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01430-3&doi=10.1016/j.jval.2021.04.1213
First page :
Section Title :
Open access? :
No
Section Order :
10699